Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anne Naevestad is active.

Publication


Featured researches published by Anne Naevestad.


Magnetic Resonance Imaging | 1997

Crystal size and properties of superparamagnetic iron oxide (SPIO) particles

Carl E. Sjøgren; Christer Johansson; Anne Naevestad; Per C. Sontum; Karen C. Briley-Saebo; Anne Kjersti Fahlvik

The properties of a superparamagnetic iron oxide (SPIO) model contrast agent have been studied. The test material, HEP-SPIO, contained iron oxide multicrystal agglomerates coated with heparin, polyanionic, naturally occurring glycosaminoglycan. Fractionation of the HEP-SPIO suspension showed the existence of colloidally stable particles ranging from approx. 100 nm down to single crystal sizes. The small (< 20 nm) particles represented the major number fraction of particles present, but only approx. 2% of the total iron oxide mass. The volume weighted average diameter of the individual iron oxide crystals forming the multicrystal agglomerates was found to be 11-12 nm using transmission electron microscopy and vibrating sample magnetometry (VSM) techniques. Comparable results were obtained with X-ray diffraction and Mössbauer spectroscopy. A number of additional SPIO properties could also be determined on a routine VSM, such as the distribution standard deviation for the log-normal distribution of crystal sizes, the magnetic susceptibility, the magnetic remanence, and the intrinsic magnetization (magnetic moment) of the iron oxide. These parameters are useful tools for evaluation of the magnetic characteristics and contrast efficacy of SPIO contrast agents.


Archive | 1997

Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors

Jo Klaveness; Pal Rongved; Anders Høgset; Helge Tolleshaug; Anne Naevestad; Halldis Hellebust; Lars Hoff; Alan Cuthbertson; Dagfinn Løvhaug; Magne Solbakken


Archive | 2001

Diagnostic/therapeutic agents

Jo Klaveness; Pal Rongved; Anders Høgset; Helge Tolleshaug; Alan Cuthbertson; Aslak Godal; Lars Hoff; Geir Gogstad; Klaus Bryn; Anne Naevestad; Dagfinn Løvhaug; Halldis Hellebust; Magne Solbakken


Archive | 1997

Improvements in or relating to diagnostic/therapeutic agents

Jo Klaveness; Pal Rongved; Anders Høgset; Helge Tolleshaug; Anne Naevestad; Halldis Hellebust; Lars Hoff; Alan Cuthbertson; Dagfinn Løvhaug; Magne Solbakken


Archive | 1999

Ultrafine lightly coated superparamagnetic particles for MRI

Anne Kjersti Fahlvik; Anne Naevestad; Helge Guttorm Gundersen; Per Strande; Jo Klaveness; Anne Jacobsen


Archive | 1998

Contrast agents targetting receptors associated with angiogenesis

Christopher Black; Anne Naevestad; Henry Wolfe


Archive | 1998

Diagnostic imaging technique

Jo Klaveness; Anne Naevestad; Christopher Black; Henry Wolfe


Archive | 1998

Kontrastmittel, die auf angiogenese-rezeptoren zielen Contrast agents that target angiogenesis receptors

Jo Klaveness; Anne Naevestad; Christopher Black; Henry Wolfe; Helge Tolleshaug


Archive | 1998

Kontrastmittel, die auf angiogenese-rezeptoren zielen Contrast agents that target angiogenesis-adrenergic receptor

Christopher Black; Jo Klaveness; Anne Naevestad; Helge Tolleshaug; Henry Wolfe


Archive | 1998

Method of imaging

Christopher Black; Anne Naevestad; Henry Wolfe

Collaboration


Dive into the Anne Naevestad's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge